Project Grant HT94252510417
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Plandome, NY 11030, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $299,937.00 to The Feinstein Institutes For Medical Research to conduct research on visualizing neural synaptic density in systemic lupus erythematosus (SLE) to better understand mechanisms of brain dysfunction. The award period runs from July 15, 2024 to July 14, 2026. The Feinstein Institutes, a non-profit research organization, will utilize this...
This $1,339,689 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by The Feinstein Institutes for Medical Research to identify and characterize metastasis-driving tumor cell subpopulations in localized stage III clear cell renal cell carcinoma. The 4-year award from Aug 1, 2024 to Jul 31, 2028 will support this advanced biomedical research initiative focused on transforming healthcare for military...
The Project Grant award of $1,000,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will support research conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, to investigate the neural substrates of fatigue and impaired cognition in individuals with lupus, a condition also known as "lupus brain fog." The research aims to advance...
This federal Project Grant award of $997,821.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. The primary awardee, Trustees of Dartmouth College, will conduct research to investigate the pathogenic role of neutrophil subpopulations in lupus nephritis. The project includes sub-awards to The...
This $299,998 Project Grant award was provided by the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Nebraska Medical Center (UNMC). The award will support a 2-year research project from July 2024 to July 2026 entitled "VAP-1 AND METHYLGLYOXAL AS NOVEL TARGETS IN LUPUS NEPHRITIS". Through this funding, UNMC will conduct innovative biomedical research to investigate new treatment approaches for lupus nephritis, a...
The Feinstein Institutes for Medical Research received a $921,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a study from August 15, 2022 to August 14, 2025 to research microglia as potential therapeutic targets for Autism Spectrum Disorder (ASD) using a mouse model of maternal anti-Caspr2 antibody-induced ASD. The Military Medical Research and Development program supports...
Yale University received a $1,731,409 project grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The U.S. Department of the Army Medical Command awarded a $472,560 project grant to Beth Israel Deaconess Medical Center, Inc. (Bidmc) under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports advanced biomedical research to develop innovative therapeutic approaches for treating genetic forms of focal segmental glomerulosclerosis (FSGS), a rare kidney disorder. The two-year project, running from January 1, 2025 to December 31, 2026, will focus on...
This federal Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, provides $1,000,000.00 to the Jackson Laboratory in Bar Harbor, Maine to support research aimed at "Uncovering Spatial and Temporal Alterations of Metabolism in the Kidney, Paving the Road to Treatment of Lupus Nephritis." The award period spans 3 years from May 15, 2025 to May 14, 2028. As a leading nonprofit biomedical...
Yale University received a $1,618,571 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The award will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...